Skip to main content
. 2021 Apr 3;88(3):471–480. doi: 10.1016/j.bjorl.2021.03.003

Table 3.

Evaluation of response to initial treatment (4–6 months) with immunobiologicals.

At least 2 criteria:
Improved sense of smell (at least 1 degree in olfactory classification, eg from moderate hyposmia to mild hyposmia)
Improved nasal congestion (at least 2 points on VAS)
Decrease in nasal polyp – decrease of 2 points in the Lund-Kennedy endoscopic score (sum of right and left side)
Asthma Control
SNOT-22 reduction ≥9